top of page

Monthly HealthRISC Overview | Mississippi Board of Pharmacy

Don't get behind on state and federal changes that may be impacting your business. Stay in the know with our HealthRISC Report, capturing any and all regulatory changes, including the Mississippi Board of Pharmacy's newly proposed regulation for pharmaceutical facility permits.


The proposed amendments to the current rules includes a multitude of guidelines, such as necessary application information, designated representative requirements, as well as operational specifications. In addition to the revised guidelines, specific prohibited acts were also mentioned, which included how no facility/business may engage in wholesale distribution of a prescription drug, APIs, or devices in or into Mississippi only if the facility/business is licensed/permitted by either the state from which the drug, API, or device is distributed or by the state into which the drug, API, or device is distributed. The comment period is open until 2/17/23.





Resources:






Σχόλια


bottom of page